Immunotech Market Cap from 2010 to 2026
| IMMB Stock | USD 0.0001 0.00 0.00% |
Market Cap | First Reported 2010-12-31 | Previous Quarter 51.5 K | Current Value 54.1 K | Quarterly Volatility 14.1 K |
Check Immunotech Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunotech Laboratories' main balance sheet or income statement drivers, such as , as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0113. Immunotech financial statements analysis is a perfect complement when working with Immunotech Laboratories Valuation or Volatility modules.
Immunotech | Market Cap | Build AI portfolio with Immunotech Stock |
Analyzing Immunotech Laboratories's Market Cap over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Market Cap has evolved provides context for assessing Immunotech Laboratories's current valuation and future prospects.
Latest Immunotech Laboratories' Market Cap Growth Pattern
Below is the plot of the Market Cap of Immunotech Laboratories over the last few years. It is Immunotech Laboratories' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immunotech Laboratories' overall financial position and show how it may be relating to other accounts over time.
| Market Cap | 10 Years Trend |
|
Market Cap |
| Timeline |
Immunotech Market Cap Regression Statistics
| Arithmetic Mean | 51,008 | |
| Geometric Mean | 25,292 | |
| Coefficient Of Variation | 27.72 | |
| Mean Deviation | 8,534 | |
| Median | 57,270 | |
| Standard Deviation | 14,137 | |
| Sample Variance | 199.9M | |
| Range | 57.3K | |
| R-Value | 0.56 | |
| Mean Square Error | 147.3M | |
| R-Squared | 0.31 | |
| Significance | 0.02 | |
| Slope | 1,556 | |
| Total Sum of Squares | 3.2B |
Immunotech Market Cap History
About Immunotech Laboratories Financial Statements
Immunotech Laboratories stakeholders use historical fundamental indicators, such as Immunotech Laboratories' Market Cap, to determine how well the company is positioned to perform in the future. Although Immunotech Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Immunotech Laboratories' assets and liabilities are reflected in the revenues and expenses on Immunotech Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Immunotech Laboratories. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Market Cap | 51.5 K | 54.1 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Immunotech Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immunotech Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immunotech Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immunotech Laboratories Stock:Check out the analysis of Immunotech Laboratories Correlation against competitors. For information on how to trade Immunotech Stock refer to our How to Trade Immunotech Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunotech Laboratories. Market participants price Immunotech higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Immunotech Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.30) |
Immunotech Laboratories's market price often diverges from its book value, the accounting figure shown on Immunotech's balance sheet. Smart investors calculate Immunotech Laboratories' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Immunotech Laboratories' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Immunotech Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunotech Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunotech Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.